Publicaciones en las que colabora con Jan C.C. Borleffs (8)

2009

  1. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2008

  1. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

    Clinical Infectious Diseases, Vol. 46, Núm. 7, pp. 1101-1110

  2. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

    AIDS, Vol. 22, Núm. 16, pp. 2143-2153

2007

  1. Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

    Journal of Acquired Immune Deficiency Syndromes, Vol. 46, Núm. 5, pp. 607-615

2006

  1. Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D Study

    Archives of Internal Medicine, Vol. 166, Núm. 15, pp. 1632-1641

2005

  1. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

    Clinical Infectious Diseases, Vol. 41, Núm. 12, pp. 1772-1782

2004

  1. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

    Lancet, Vol. 364, Núm. 9428, pp. 51-62

2003

  1. Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group

    New England Journal of Medicine, Vol. 349, Núm. 21, pp. 1993-2003